Seizures induced by the combination treatment of methylphenidate and sertraline

Journal of Child and Adolescent Psychopharmacology

Volumn 18, Issue 3, 2008, Pages 301-303

  Schertz, Mitchell ^a   Steinberg, Tamar ^b  

^a Institute for Child Development   (Israel)

^b SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLONIDINE; METHYLPHENIDATE; SERTRALINE;

ANXIETY; ATTENTION DEFICIT DISORDER; CASE REPORT; CHILD; COMORBIDITY; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; EPILEPTIC DISCHARGE; FEMALE; HUMAN; LANGUAGE; LETTER; MEMORY; PERCEPTION; SCHOOL CHILD; SEIZURE; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION;

CHILD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; METHYLPHENIDATE; SEIZURES; SERTRALINE;

EID: 58149197858     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2007.0141     Document Type: Letter

References (15)

1. Feeney DJ, Klykylo WM : Medication-induced seizures. J Am Acad Child Adolesc Psychiatry 36:1018-1019, 1997.
2. Findling RL: Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin re-uptake inhibitors and psychostimulants in children, adolescents, and adults: A case series. J Child Adolesc Psychopharmacol 6:165-175, 1996.
3. Gross-Tsur V, Manor O, van der Meere J, Joseph A, Shalev RS : Epilepsy and attention deficit hyperactivity disorder: Is methylphenidate safe and effective? J Pediatr 130:670-674, 1997.
4. Isbister GK, Bowe SJ, Dawson A, Whyte IM: Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol 42:277-285, 2004.
5. Kafka MP, Hennen J: Psychostimulant augmentation during treatment with selective serotonin reuptake inhibitors in men with paraphilias and paraphilia-related disorders: A case series. J Clin Psychiatry 61:664-670, 2000.
6. Kanner AM, Kozak AM, Frey M: The use of sertraline in patients with epilepsy: Is it safe? Epilepsy Behav 1:100-105, 2000.
7. Lavretsky H, Park S, Siddarth P, Kumar A, Reynolds CF: Methylphenidate-enhanced antidepressant response to citalopram in the elderly: A double-blind, placebo-controlled pilot trial. Am J Geriatr Psychiatry 14:181-185, 2006.
8. McGlohn SE, Bostwick JM: Sertraline with methylphenidate in an ICU patient. Psychosomatics 36:584-585, 1995.
9. Patkar AA, Masand PS, Pae CU, Peindl K, Hooper-Wood C, Mannelli P, Ciccone P: A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression. J Clin Psychopharmacol 26:653-656, 2006.
10. Postolache TT, Rosenthal RN, Hellerstein DJ, Aromin R, Kelton GM, Muran JC, Londono JH: Early augmentation of sertraline with methylphenidate. J Clin Psychiatry 60:123-124, 1999.
11. Schatz DB, Rostain AL: ADHD with comorbid anxiety: A review. J Atten Disord 10:141-149, 2006.
12. Silvestri R, Gagliano A, Calarese T, Aricò I, Cedro C, Condurso R, Germanò E,Vita G, Tortorella G: Ictal and interictal EEG abnormalities in ADHD children recorded over night by video-polysomnography. Epilepsy Res 75:130-137, 2007.
13. Stoll AL, Pillay SS, Diamond L, Workum SB, Cole JO: Methylphenidate augmentation of serotonin selective reuptake inhibitors: A case series. J Clin Psychiatry 57:72-76, 1996.
14. Thomé-Souza MS, Kuczynski E, Valente KD: Sertraline and fluoxetine: Safe treatments for children and adolescents with epilepsy and depression. Epilepsy Behav 10:417-425, 2007.
15. Waxmonsky J: Assessment and treatment of attention deficit hyperactivity disorder in children with comorbid psychiatric illness. Curr Opin Pediatr 15:476-482, 2003.